One of Hong Kong's most high-profile insider trading cases is back in focus, as a trial involving Segantii Capital Management and its founder Simon Sadler began in the city on Monday. Bloomberg's Minmin Low has the latest.
Shaojing Tong, CFO at Chinese biotech firm RemeGen, discusses the company's first quarter results and shares his confidence in growth in the domestic market. The company's stock has outperformed all of its peers in the MSCI China Healthcare Index since the start of the year.
From a memory crunch to global instability, Lenovo CFO Winston Cheng and NF Trinity's Helen Zhu discuss the roadmap for AI growth and the hurdles facing the global tech buildout.
'Reputation, trust, and confidence of the market is central to everything', says Hong Kong Financial Secretary Paul Chan as the government's number one priority is to ensure a continuous supply of quality issuers coming to the market.
HKEX chief executive Bonnie Chan says the Hong Kong exchange has attracted a diverse range of IPO applicants, from different sectors and geographies. She tells Bloomberg's Stephen Engle that this will help the exchange weather uncertainty around the AI sector.
_1393237_640x360_2498712643514-640x360.webp&w=3840&q=75)
_1389209_640x360_2498158659681-640x360.webp&w=3840&q=75)
_1384055_640x360_2497148483656-640x360.webp&w=3840&q=75)
